CD69: from activation marker to metabolic gatekeeper

European Journal of Immunology

Volumn 47, Issue 6, 2017, Pages 946-953

  Cibrián, Danay ^a,b,c   Sánchez Madrid, Francisco ^a,b,c  

^a Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c CIBERCV   (Spain)

Author keywords

CD69; Galectin 1; LAT1; Metabolism; mTOR; S1P1; T cells

Indexed keywords

CD69 ANTIGEN; GALECTIN 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; STAT5 PROTEIN; CYTOKINE; GALECTIN; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

AMINO ACID TRANSPORT; ANTIGEN PRESENTING CELL; DENDRITIC CELL; EFFECTOR CELL; GAMMA DELTA T LYMPHOCYTE; HELPER CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MEMBRANE; MEMORY T LYMPHOCYTE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINES; GALECTINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 85020486627     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646837     Document Type: Review

References (63)

1. Ziegler, S. F., Ramsdell, F., Hjerrild, K. A., Armitage, R. J., Grabstein, K. H., Hennen, K. B., Farrah, T. et al., Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 1993. 23: 1643–1648.
2. Lopez-Cabrera, M., Santis, A. G., Fernandez-Ruiz, E., Blacher, R., Esch, F., Sanchez-Mateos, P. and Sanchez-Madrid, F., Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 1993. 178: 537–547.
3. Lopez-Cabrera, M., Munoz, E., Blazquez, M. V., Ursa, M. A., Santis, A. G. and Sanchez-Madrid, F., Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J. Biol. Chem. 1995. 270: 21545–21551.
4. Castellanos, M. C., Munoz, C., Montoya, M. C., Lara-Pezzi, E., Lopez-Cabrera, M. and de Landazuri, M. O., Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1. J. Immunol. 1997. 159: 5463–5473.
5. Gonzalez-Amaro, R., Cortes, J. R., Sanchez-Madrid, F. and Martin, P., Is CD69 an effective brake to control inflammatory diseases? Trends Mol. Med. 2013. 19: 625–632.
6. Afeltra, A., Galeazzi, M., Ferri, G. M., Amoroso, A., De Pita, O., Porzio, F. and Bonomo, L., Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann. Rheum. Dis. 1993. 52: 457–460.
7. Crispin, J. C., Martinez, A., de Pablo, P., Velasquillo, C. and Alcocer-Varela, J., Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand. J. Immunol. 1998. 48: 196–200.
8. Radstake, T. R., van Bon, L., Broen, J., Hussiani, A., Hesselstrand, R., Wuttge, D. M., Deng, Y. et al., The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009. 4: e5903.
9. Julius, P., Luttmann, W., Knoechel, B., Kroegel, C., Matthys, H. and Virchow, J. C., Jr., CD69 surface expression on human lung eosinophils after segmental allergen provocation. Eur. Respir. J. 1999. 13: 1253–1259.
10. Toma, T., Mizuno, K., Okamoto, H., Kanegane, C., Ohta, K., Ikawa, Y., Miura, M. et al., Expansion of activated eosinophils in infants with severe atopic dermatitis. Pediatr. Int. 2005. 47: 32–38.
11. Lauzurica, P., Sancho, D., Torres, M., Albella, B., Marazuela, M., Merino, T., Bueren, J. A. et al., Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 2000. 95: 2312–2320.
12. Alari-Pahissa, E., Notario, L., Lorente, E., Vega-Ramos, J., Justel, A., Lopez, D., Villadangos, J. A. et al., CD69 does not affect the extent of T cell priming. PLoS One 2012. 7: e48593.
13. Sancho, D., Gomez, M., Viedma, F., Esplugues, E., Gordon-Alonso, M., Garcia-Lopez, M. A., de la Fuente, H. et al., CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J. Clin. Invest. 2003. 112: 872–882.
14. Martin, P., Gomez, M., Lamana, A., Matesanz Marin, A., Cortes, J. R., Ramirez-Huesca, M., Barreiro, O. et al., The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J. Allergy. Clin. Immunol. 2010. 126: 355–365, 365 e351-353.
15. Cruz-Adalia, A., Jimenez-Borreguero, L. J., Ramirez-Huesca, M., Chico-Calero, I., Barreiro, O., Lopez-Conesa, E., Fresno, M. et al., CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation 2010. 122: 1396–1404.
16. Vega-Ramos, J., Alari-Pahissa, E., Valle, J. D., Carrasco-Marin, E., Esplugues, E., Borras, M., Martinez, A. C. et al., CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection. Immunol. Cell Biol. 2010. 88: 707–715.
17. Esplugues, E., Sancho, D., Vega-Ramos, J., Martinez, C., Syrbe, U., Hamann, A., Engel, P. et al., Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 2003. 197: 1093–1106.
18. Radulovic, K., Manta, C., Rossini, V., Holzmann, K., Kestler, H. A., Wegenka, U. M., Nakayama, T. et al., CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J. Immunol. 2012. 188: 2001–2013.
19. Radulovic, K., Rossini, V., Manta, C., Holzmann, K., Kestler, H. A. and Niess, J. H., The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine. PLoS One 2013. 8: e65413.
20. Hasegawa, A., Iwamura, C., Kitajima, M., Hashimoto, K., Otsuyama, K., Ogino, H., Nakayama, T. et al., Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis. PLoS One 2013. 8: e65494.
21. de la Fuente, H., Cruz-Adalia, A., Martinez Del Hoyo, G., Cibrian-Vera, D., Bonay, P., Perez-Hernandez, D., Vazquez, J. et al., The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1. Mol. Cell Biol. 2014. 34: 2479–2487.
22. Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W. et al., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007. 8: 825–834.
23. Martin, P., Gomez, M., Lamana, A., Cruz-Adalia, A., Ramirez-Huesca, M., Ursa, M. A., Yanez-Mo, M. et al., CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol. Cell Biol. 2010. 30: 4877–4889.
24. Cedeno-Laurent, F., Opperman, M., Barthel, S. R., Kuchroo, V. K. and Dimitroff, C. J., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 2012. 188: 3127–3137.
25. Lin, C. R., Wei, T. Y., Tsai, H. Y., Wu, Y. T., Wu, P. Y. and Chen, S. T., Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation. FASEB J. 2015. 29: 5006–5017.
26. Shiow, L. R., Rosen, D. B., Brdickova, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G. et al., CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006. 440: 540–544.
27. Cibrian, D., Saiz, M. L., de la Fuente, H., Sanchez-Diaz, R., Moreno-Gonzalo, O., Jorge, I., Ferrarini, A. et al., CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat. Immunol. 2016. 17: 985–996.
28. Pollizzi, K. N. and Powell, J. D., Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 2014. 14: 435–446.
29. Yang, X. P., Ghoreschi, K., Steward-Tharp, S. M., Rodriguez-Canales, J., Zhu, J., Grainger, J. R., Hirahara, K. et al., Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 2011. 12: 247–254.
30. Cortes, J. R., Sanchez-Diaz, R., Bovolenta, E. R., Barreiro, O., Lasarte, S., Matesanz-Marin, A., Toribio, M. L. et al., Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression. J. Autoimmun. 2014. 55: 51–62.
31. Sanchez-Diaz, R., Blanco-Dominguez, R., Lasarte, S., Tsilingiri, K., Martin-Gayo, E., Linillos-Pradillo, B., de la Fuente, H. et al., Thymus-derived Treg cell development is regulated by C-type-lectin-mediated BIC/miRNA155 expression. Mol. Cell Biol. 2017. 31: e00341-16.
32. Barbi, J., Pardoll, D. and Pan, F., Metabolic control of the Treg/Th17 axis. Immunol. Rev. 2013. 252: 52–77.
33. Liu, G., Yang, K., Burns, S., Shrestha, S. and Chi, H., The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat. Immunol. 2010. 11: 1047–1056.
34. Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y. B., Taylor, P. M. and Cantrell, D. A., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 2013. 14: 500–508.
35. Spiegel, S. and Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 2011. 11: 403–415.
36. Hunter, M. C., Teijeira, A. and Halin, C., T cell trafficking through lymphatic vessels. Front. Immunol. 2016. 7: 613.
37. Bankovich, A. J., Shiow, L. R. and Cyster, J. G., CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J. Biol. Chem. 2010. 285: 22328–22337.
38. Hervier, B., Beziat, V., Haroche, J., Mathian, A., Lebon, P., Ghillani-Dalbin, P., Musset, L. et al., Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-gamma production in patients with active disease. Arthritis. Rheum. 2011. 63: 1698–1706.
39. Feng, C., Woodside, K. J., Vance, B. A., El-Khoury, D., Canelles, M., Lee, J., Gress, R. et al., A potential role for CD69 in thymocyte emigration. Int. Immunol. 2002. 14: 535–544.
40. Nakayama, T., Kasprowicz, D. J., Yamashita, M., Schubert, L. A., Gillard, G., Kimura, M., Didierlaurent, A. et al., The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 2002. 168: 87–94.
41. Schulz, O., Ugur, M., Friedrichsen, M., Radulovic, K., Niess, J. H., Jalkanen, S., Krueger, A. et al., Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress. Mucosal Immunol. 2014. 7: 892–904.
42. Shinoda, K., Tokoyoda, K., Hanazawa, A., Hayashizaki, K., Zehentmeier, S., Hosokawa, H., Iwamura, C. et al., Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc. Natl. Acad. Sci. U. S. A. 2012. 109: 7409–7414.
43. Lamana, A., Martin, P., de la Fuente, H., Martinez-Munoz, L., Cruz-Adalia, A., Ramirez-Huesca, M., Escribano, C. et al., CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. J. Invest. Dermatol. 2011. 131: 1503–1512.
44. Mackay, L. K. and Kallies, A., Transcriptional Regulation of Tissue-Resident Lymphocytes. Trends Immunol. 2017. 38: 94–103.
45. Mackay, L. K., Rahimpour, A., Ma, J. Z., Collins, N., Stock, A. T., Hafon, M. L., Vega-Ramos, J. et al., The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 2013. 14: 1294–1301.
46. Mackay, L. K., Braun, A., Macleod, B. L., Collins, N., Tebartz, C., Bedoui, S., Carbone, F. R. et al., Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 2015. 194: 2059–2063.
47. Skon, C. N., Lee, J. Y., Anderson, K. G., Masopust, D., Hogquist, K. A. and Jameson, S. C., Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 2013. 14: 1285–1293.
48. Park, S. L., Mackay, L. K. and Gebhardt, T., Distinct recirculation potential of CD69+CD103- and CD103+ thymic memory CD8+ T cells. Immunol. Cell Biol. 2016. 94: 975–980.
49. Takamura, S., Yagi, H., Hakata, Y., Motozono, C., McMaster, S. R., Masumoto, T., Fujisawa, M. et al., Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance. J. Exp. Med. 2016. 213: 3057–3073.
50. Zaid, A., Mackay, L. K., Rahimpour, A., Braun, A., Veldhoen, M., Carbone, F. R., Manton, J. H. et al., Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl. Acad. Sci. U. S. A. 2014. 111: 5307–5312.
51. Smirnova, A., Wincent, E., Vikstrom Bergander, L., Alsberg, T., Bergman, J., Rannug, A. and Rannug, U., Evidence for new light-independent pathways for generation of the endogenous aryl hydrocarbon receptor agonist FICZ. Chem. Res. Toxicol. 2016. 29: 75–86.
52. Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M. et al., The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 2014. 20: 61–72.
53. Nakaya, M., Xiao, Y., Zhou, X., Chang, J. H., Chang, M., Cheng, X., Blonska, M. et al., Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 2014. 40: 692–705.
54. Ramsay, G. and Cantrell, D., Environmental and metabolic sensors that control T cell biology. Front. Immunol. 2015. 6: 99.
55. Carr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M. et al., Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 2010. 185: 1037–1044.
56. Conde, M., Montano, R., Moreno-Aurioles, V. R., Ramirez, R., Sanchez-Mateos, P., Sanchez-Madrid, F. and Sobrino, F., Anti-CD69 antibodies enhance phorbol-dependent glucose metabolism and Ca2+ levels in human thymocytes. Antagonist effect of cyclosporin A. J. Leukoc. Biol. 1996. 60: 278–284.
57. Labiano, S., Meléndez-Rodríguez, F., Palazón, A., Teijeira, Á., Garasa, S., Etxeberria, I., Aznar, M. Á. et al., CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes. OncoImmunology 2017. 6: e1283468.
58. Howie, D., Waldmann, H. and Cobbold, S., Nutrient sensing via mTOR in T cells maintains a tolerogenic microenvironment. Front. Immunol. 2014. 5: 409.
59. Dang, E. V., Barbi, J., Yang, H. Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z. et al., Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011. 146: 772–784.
60. Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P. and Chi, H., mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013. 499: 485–490.
61. Garris, C. S., Wu, L., Acharya, S., Arac, A., Blaho, V. A., Huang, Y., Moon, B. S. et al., Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat. Immunol. 2013. 14: 1166–1172.
62. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M. et al., Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008. 453: 65–71.
63. Mascanfroni, I. D., Takenaka, M. C., Yeste, A., Patel, B., Wu, Y., Kenison, J. E., Siddiqui, S. et al., Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 2015. 21: 638–646.